Hot Seat

Relive the magic of Pop-up

Missed the inaugural Innovators Pop-up?  Check out our photo gallery below to get a peak at the innovators, sponsors, and attendees that brought the event to life! 

Immerse
yourself in
INNOVATION

Judges

Ehsan Sadri, M.D. FACS

Founder and CEO

Ehsan Sadri, M.D. FACS is CEO and Founder of Visionary Eye Institute with locations to serve patients in Newport Beach, Santa Ana, Orange and more locations to come. He is also General Partner, and co-founder of Visionary Ventures Fund (Visionaryvc.com). Ehsan Sadri, M.D., FACS, FAAO is board-certified, fellowship-trained in treating LASIK, cataract and glaucoma surgeries. He is trained in the most progressive ocular surgical techniques including cataract surgery, phakic intraocular lenses, LASIK, PRK, refractive lensectomy, and AK. Dr. Ehsan Sadri has performed thousands of eye surgeries utilizing advanced techniques for treatment of myopia (nearsightedness), hyperopia (farsightedness), and astigmatism.

Dr. Ehsan Sadri is well regarded as a thought leader and an active speaker at many Ophthalmology conferences where he teaches other eye surgeons the latest techniques for vision correction and preservation.

Dr. Sadri received his undergraduate degree in biochemistry and Spanish from the University of California, Davis. He obtained his medical education at the University of Michigan in Ann Arbor. There he completed a prestigious Fight for Sight fellowship in retina and glaucoma research at the highly esteemed Kellogg Eye Center. He completed his internship at the Arrowhead Regional Medical Center affiliated with UC Irvine. Dr. Sadri completed his ophthalmology residency at the University of Maryland in Baltimore and his glaucoma and cataract fellowship at the University of California, Irvine. Dr. Sadri’s research has been presented at national ophthalmologic meetings and published medical journals. He has performed numerous clinical trials involving new medications for glaucoma and innovative laser treatments.

His specialties include: Premium IOL and complex cataract surgeries; glaucoma, shunt and Minimally Invasive Glaucoma Surgeries (MIGS), and Oculoplastics.

Andrew Stewart

President, Global Pharmaceuticals and International Consumer

Andrew Stewart has more than 25 years of experience in the pharmaceutical industry and currently serves as President of Global Pharmaceuticals and International Consumer Products for Bausch + Lomb.

Mr. Stewart joined Bausch + Lomb from AbbVie, where he served as General Manager within the Eye Care franchise. At AbbVie and its predecessor, Allergan, he led the U.S. Retina business, global marketing for Eye Care and business development initiatives.

Earlier in his career, Mr. Stewart served at Bristol Meyers Squibb years in R&D, and at Merck & Co., Inc. in manufacturing.

Mr. Stewart earned an MBA from the New York University Stern School of Business and a master’s degree in Environmental Science from Rutgers University.

Ryan Zimmerman

Equity Research Analyst - Medical Technology

Ryan Zimmerman is a Managing Director and Medical Technology Analyst at BTIG. He provides coverage across the medical technology sector, focusing primarily on orthopedic and surgical companies. Prior to BTIG, Mr. Zimmerman was a Senior Associate at Canaccord Genuity, providing medical technology coverage with an emphasis on musculoskeletal companies. Previously, he was the Director of Surgery at Advocate Christ Medical Center, where he oversaw operations for a Level 1 Trauma hospital in the Chicago area. Mr. Zimmerman also held hospital management roles at Presence Health, and was a Fellow in Hospital Management at the University of Pennsylvania Health System. He is board certified in hospital management, and is a Fellow in the American College of Healthcare Executives. Mr. Zimmerman earned a BS in anthropology and zoology from the University of Michigan, and a Masters of Healthcare Administration from the University of Illinois-Chicago School of Public Health.

Kristen Ingenito, MBA

CEO

Kristen, CEO of Market Scope, has nearly two decades of experience in the ophthalmic industry, with 16 of those years spent analyzing data and ophthalmic market segments for Market Scope. She earned her MBA from the George Washington University School of Business as a Forte Fellow. She is a frequent speaker at ophthalmic meetings around the world and proudly serves on the board of directors for Ophthalmic World Leaders (OWL).